- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
ACR meeting to highlight digital mammography
With Food and Drug Administration approval for a full-field digital mammography system finally arriving this year, the new imaging technique will be a hot topic at the American College of Radiology’s 29th conference on breast cancer in San
With Food and Drug Administration approval for a full-field digital mammography system finally arriving this year, the new imaging technique will be a hot topic at the American College of Radiologys 29th conference on breast cancer in San Francisco.
The meeting will be held April 8 through 11 at the San Francisco Hilton.
In addition to digital mammography, panels at the convention will cover malpractice, breast cancer diagnosis, breast pathology, and management dilemmas.
The FDA gave premarket approval for GE Medical Systems full-field digital mammography unit, the Senographe 2000D, in February. GE will display the system at the conferences exhibit hall, said Amy Hobert, GEs mammography marketing manager.
We wont be doing a lecture (using the system) but we will have a hands-on demonstration, and well have written information about the machine, Hobert said.
GE has sold 15 Senographe 2000Ds in the U.S. and 25 in Europe, according to Hobert.
GE has FDA approval to market the $500,000 unit for hard-copy use only. This means system users will be limited initially to reading digitally processed hard copies. Marketing the unit as a hard-copy device will give clinicians time to become familiar with the new technology before its marketed in soft-copy, said Charlie Young, GE spokesperson (SCAN 2/16/00).
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.
